Baseline PSA testing for men in their 40s: testing in average-risk men aged 40 to 50 years should not be routinely performed.
H Ballentine
HB
Carter
D000328:Adult; D055088:Early Detection of Cancer / Q000379:methods* / Q000706:statistics & numerical data*; D006801:Humans; D007610:Kallikreins / Q000097:blood*; D008297:Male; D008403:Mass Screening / Q000379:methods* / Q000706:statistics & numerical data*; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis
C549870:KLK3 protein, human; D007610:Kallikreins; D017430:Prostate-Specific Antigen